RUA Life Sciences PLC

RUA

Company Profile

  • Business description

    RUA Life Sciences PLC is engaged in the contract design and manufacture of medical devices, exploiting the value of its IP and know-how, and developing cardiovascular devices. The Biomaterials segment is a licensor of Elast-Eon polymers to the medical device industry. The Medical Devices & Components segment is an end-to-end contract developer and manufacturer of medical devices and an implantable fabric specialist, which generates maximum revenue. The Vascular segment focuses on the development and commercialisation of the Group's Elast-Eon sealed Vascular Graft products. The Structural Heart segment focuses on the development of the Group's tri-leaflet polymeric heart valves. Geographically, it operates in Europe, North America, Middle East, Asia Pacific, and Africa.

  • Contact

    2 Drummond Crescent
    Scotland
    IrvineAyrshireKA11 5AN
    GBR

    T: +44 1294317073

    E: [email protected]

    https://www.rualifesciences.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 March 2027

    Employees

    59

Stocks News & Analysis

stocks

ASX tech share tracking below guidance

Moat Rating downgraded for overvalued shares.
stocks

After plunge ASX blue chip undervalued

This company earns a moat from our analysts.
stocks

Older cohorts the budget losers, not necessarily the ASX listed insurers

Proposed legislation removes health insurance rebates.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,717.0082.40-0.94%
CAC 408,047.9166.150.83%
DAX 4024,527.53126.880.52%
Dow JONES (US)49,382.8618.980.04%
FTSE 10010,374.2843.730.42%
HKSE25,651.12146.73-0.57%
NASDAQ26,038.88168.170.65%
Nikkei 22559,804.41746.18-1.23%
NZX 50 Index12,761.03213.29-1.64%
S&P 5007,381.3227.710.38%
S&P/ASX 2008,496.6076.50-0.89%
SSE Composite Index4,162.187.35-0.18%

Market Movers